{"address1": "201 Haskins Way", "address2": "Suite 230", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "215 731 9450", "website": "https://www.cero.bio", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Mr. Christopher B. Ehrlich M.B.A.", "age": 54, "title": "CEO & Chair", "yearBorn": 1970, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lawrence  Corey M.D.", "age": 76, "title": "Co-founder & Head of Scientific Advisory Board", "yearBorn": 1948, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew Albert Kucharchuk M.B.A.", "age": 43, "title": "Chief Financial Officer", "yearBorn": 1981, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Kristen  Pierce Ph.D.", "age": 54, "title": "Chief Development Officer", "yearBorn": 1970, "exercisedValue": 0, "unexercisedValue": 0}], "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.73, "open": 0.6868, "dayLow": 0.6501, "dayHigh": 0.7789, "regularMarketPreviousClose": 0.73, "regularMarketOpen": 0.6868, "regularMarketDayLow": 0.6501, "regularMarketDayHigh": 0.7789, "payoutRatio": 0.0, "beta": 0.427, "volume": 329221, "regularMarketVolume": 329221, "averageVolume": 862254, "averageVolume10days": 1356050, "averageDailyVolume10Day": 1356050, "bid": 0.5229, "ask": 0.8456, "bidSize": 2, "askSize": 1, "marketCap": 2181549, "fiftyTwoWeekLow": 0.65, "fiftyTwoWeekHigh": 223.0, "fiftyDayAverage": 1.55458, "twoHundredDayAverage": 10.993445, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 3089594, "profitMargins": 0.0, "floatShares": 1051226, "sharesOutstanding": 3029930, "sharesShort": 843621, "sharesShortPriorMonth": 331028, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.2784, "heldPercentInsiders": 0.18537001, "heldPercentInstitutions": 0.044699997, "shortRatio": 1.74, "shortPercentOfFloat": 0.3673, "impliedSharesOutstanding": 3029930, "bookValue": -4.938, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -5488153, "trailingEps": -118.56, "lastSplitFactor": "1:100", "lastSplitDate": 1736294400, "52WeekChange": -0.9964, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 0.72, "recommendationKey": "none", "totalCash": 3380204, "totalCashPerShare": 2.249, "totalDebt": 1804822, "quickRatio": 0.359, "currentRatio": 0.394, "returnOnAssets": -0.87565005, "freeCashflow": 8462780, "operatingCashflow": -8070260, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CERO", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1638282600000, "shortName": "CERo Therapeutics Holdings, Inc", "longName": "CERo Therapeutics Holdings, Inc.", "corporateActions": [], "regularMarketTime": 1743537601, "exchange": "NCM", "messageBoardId": "finmb_1673740339", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -1.3698617, "regularMarketPrice": 0.72, "cryptoTradeable": false, "marketState": "PRE", "regularMarketChange": -0.00999999, "regularMarketDayRange": "0.6501 - 0.7789", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 862254, "fiftyTwoWeekLowChange": 0.07000005, "fiftyTwoWeekLowChangePercent": 0.10769239, "fiftyTwoWeekRange": "0.65 - 223.0", "fiftyTwoWeekHighChange": -222.28, "fiftyTwoWeekHighChangePercent": -0.9967713, "fiftyTwoWeekChangePercent": -99.64, "epsTrailingTwelveMonths": -118.56, "fiftyDayAverageChange": -0.83457994, "fiftyDayAverageChangePercent": -0.53685236, "twoHundredDayAverageChange": -10.273445, "twoHundredDayAverageChangePercent": -0.9345064, "priceToBook": -0.14580803, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Phoenix Biotech Acquisition Corp.", "nameChangeDate": "2025-04-01", "displayName": "CERo Therapeutics", "trailingPegRatio": null}